These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18614972)

  • 21. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis.
    Fanjiang G; Russell GH; Katz AJ
    J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):312-7. PubMed ID: 17325550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab for the treatment of ulcerative colitis.
    Eshuis EJ; Bemelman WA; Stokkers PC
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.
    Selvasekar CR; Cima RR; Larson DW; Dozois EJ; Harrington JR; Harmsen WS; Loftus EV; Sandborn WJ; Wolff BG; Pemberton JH
    J Am Coll Surg; 2007 May; 204(5):956-62; discussion 962-3. PubMed ID: 17481518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
    Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Infliksimab in therapy of inflammatory bowels diseases].
    Kniazev OV; Lazebnik LB; Ruchkina IN; Tsaregorodtseva TN; Parfenov AI
    Eksp Klin Gastroenterol; 2009; (5):64-8. PubMed ID: 20201307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tolerance and efficacy of a postponed retreatment with infliximab in Crohn's disease primary responders.
    Laharie D; Chanteloup E; Chabrun E; Subtil C; Kowo M; El Hanafi K; DE Lédinghen V
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1240-8. PubMed ID: 19416134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term outcome of infliximab therapy in pediatric Crohn disease].
    Wanty C; Stephenne X; Sokal E; Smets F
    Arch Pediatr; 2011 Aug; 18(8):863-9. PubMed ID: 21723101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting: results of a prospective cohort study.
    Warman A; Straathof JW; Derijks LJ
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):242-8. PubMed ID: 25569569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infliximab in ulcerative colitis.
    Aberra FN; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
    Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgery, Crohn's disease, and the biological era: has there been an impact?
    Slattery E; Keegan D; Hyland J; O'donoghue D; Mulcahy HE
    J Clin Gastroenterol; 2011 Sep; 45(8):691-3. PubMed ID: 21135702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
    Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn's disease.
    Sazuka S; Katsuno T; Nakagawa T; Saito M; Saito K; Matsumura T; Arai M; Sato T; Yokosuka O
    Eur J Clin Nutr; 2012 Nov; 66(11):1219-23. PubMed ID: 23010687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resource utilization before and during infliximab therapy in patients with inflammatory bowel disease.
    Waters HC; Vanderpoel JE; Nejadnik B; McKenzie RS; Lunacsek OE; Lennert BJ; Goff J; Augustyn DH
    J Med Econ; 2012; 15(1):45-52. PubMed ID: 22023068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome of newly diagnosed Crohn's disease: a comparative, retrospective study before and after infliximab availability.
    Domènech E; Zabana Y; Garcia-Planella E; López San Román A; Nos P; Ginard D; Gordillo J; Martínez-Silva F; Beltrán B; Mañosa M; Cabré E; Gassull MA
    Aliment Pharmacol Ther; 2010 Jan; 31(2):233-9. PubMed ID: 19832727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients.
    Gavalas E; Kountouras J; Stergiopoulos C; Zavos C; Gisakis D; Nikolaidis N; Giouleme O; Chatzopoulos D; Kapetanakis N
    Hepatogastroenterology; 2007 Jun; 54(76):1074-9. PubMed ID: 17629042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease.
    Bousvaros A
    Expert Rev Clin Immunol; 2010 Jul; 6(4):659-66. PubMed ID: 20594138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.